Impact of Port-A-Cath device management in cancer patients with candidaemia
Summary This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outco...
Gespeichert in:
| Veröffentlicht in: | The Journal of hospital infection 2012-12, Vol.82 (4), p.281-285 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 285 |
|---|---|
| container_issue | 4 |
| container_start_page | 281 |
| container_title | The Journal of hospital infection |
| container_volume | 82 |
| creator | Lai, Y.-C Huang, L.-J Chen, T.-L Yang, Y.-W Hsiao, L.-T Teng, H.-W Fung, C.-P Chiou, T.-J Tzeng, C.-H Liu, C.-Y |
| description | Summary This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3–4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock. |
| doi_str_mv | 10.1016/j.jhin.2012.08.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1178671337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670112002800</els_id><sourcerecordid>1178671337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-3bffa4f1e908871685ac8ddb1d6d17b2a0978539e7df401737d0bbdcd1d598633</originalsourceid><addsrcrecordid>eNp9kV1rFTEQhoNY7Gn1D3gheyN4s-tMsrvJggjlYGuxoKBeh2wya7PuxzHZU-m_b5ZzVPCiV4GX550JzzD2EqFAwPptX_S3fio4IC9AFQDyCdtgJXjOG9E8ZRvApsprCXjKzmLsASDl1TN2ygWoslRiwz5djztjl2zusi9zWPKLfGuW28zRnbeUjWYyP2ikacn8lFkzWQrZziw-JTH77ROZQuedodGb5-ykM0OkF8f3nH2__PBt-zG_-Xx1vb24yW0pyyUXbdeZskNqQCmJtaqMVc616GqHsuUGGqkq0ZB0XQkohXTQts46dFWjaiHO2ZvD3F2Yf-0pLnr00dIwmInmfdSIUtUShZAJ5QfUhjnGQJ3eBT-acK8R9CpR93qVqFeJGpROElPp1XH-vh3J_a38sZaA10fARGuGLiQxPv7j6gYEFyv37sBRsnHnKehokzpLzgeyi3azf_wf7_-r28FPPm38SfcU-3kfpuRZo46po7-u516vjRyAKwDxAD2po6s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1178671337</pqid></control><display><type>article</type><title>Impact of Port-A-Cath device management in cancer patients with candidaemia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lai, Y.-C ; Huang, L.-J ; Chen, T.-L ; Yang, Y.-W ; Hsiao, L.-T ; Teng, H.-W ; Fung, C.-P ; Chiou, T.-J ; Tzeng, C.-H ; Liu, C.-Y</creator><creatorcontrib>Lai, Y.-C ; Huang, L.-J ; Chen, T.-L ; Yang, Y.-W ; Hsiao, L.-T ; Teng, H.-W ; Fung, C.-P ; Chiou, T.-J ; Tzeng, C.-H ; Liu, C.-Y</creatorcontrib><description>Summary This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3–4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2012.08.007</identifier><identifier>PMID: 23084483</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cancer ; Candidaemia ; Candidemia - therapy ; Catheter-Related Infections - epidemiology ; Cohort Studies ; Female ; Human mycoses ; Humans ; Infection Control - methods ; Infectious Disease ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Mycoses ; Mycotic sepsis ; Neoplasms - complications ; Port-A-Cath ; Removal ; Retention ; Retrospective Studies ; Totally implantable central venous access port ; Treatment Outcome ; United States ; Vascular Access Devices - microbiology</subject><ispartof>The Journal of hospital infection, 2012-12, Vol.82 (4), p.281-285</ispartof><rights>The Healthcare Infection Society</rights><rights>2012 The Healthcare Infection Society</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-3bffa4f1e908871685ac8ddb1d6d17b2a0978539e7df401737d0bbdcd1d598633</citedby><cites>FETCH-LOGICAL-c474t-3bffa4f1e908871685ac8ddb1d6d17b2a0978539e7df401737d0bbdcd1d598633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhin.2012.08.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26903233$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23084483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lai, Y.-C</creatorcontrib><creatorcontrib>Huang, L.-J</creatorcontrib><creatorcontrib>Chen, T.-L</creatorcontrib><creatorcontrib>Yang, Y.-W</creatorcontrib><creatorcontrib>Hsiao, L.-T</creatorcontrib><creatorcontrib>Teng, H.-W</creatorcontrib><creatorcontrib>Fung, C.-P</creatorcontrib><creatorcontrib>Chiou, T.-J</creatorcontrib><creatorcontrib>Tzeng, C.-H</creatorcontrib><creatorcontrib>Liu, C.-Y</creatorcontrib><title>Impact of Port-A-Cath device management in cancer patients with candidaemia</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>Summary This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3–4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Candidaemia</subject><subject>Candidemia - therapy</subject><subject>Catheter-Related Infections - epidemiology</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Human mycoses</subject><subject>Humans</subject><subject>Infection Control - methods</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycoses</subject><subject>Mycotic sepsis</subject><subject>Neoplasms - complications</subject><subject>Port-A-Cath</subject><subject>Removal</subject><subject>Retention</subject><subject>Retrospective Studies</subject><subject>Totally implantable central venous access port</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Vascular Access Devices - microbiology</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV1rFTEQhoNY7Gn1D3gheyN4s-tMsrvJggjlYGuxoKBeh2wya7PuxzHZU-m_b5ZzVPCiV4GX550JzzD2EqFAwPptX_S3fio4IC9AFQDyCdtgJXjOG9E8ZRvApsprCXjKzmLsASDl1TN2ygWoslRiwz5djztjl2zusi9zWPKLfGuW28zRnbeUjWYyP2ikacn8lFkzWQrZziw-JTH77ROZQuedodGb5-ykM0OkF8f3nH2__PBt-zG_-Xx1vb24yW0pyyUXbdeZskNqQCmJtaqMVc616GqHsuUGGqkq0ZB0XQkohXTQts46dFWjaiHO2ZvD3F2Yf-0pLnr00dIwmInmfdSIUtUShZAJ5QfUhjnGQJ3eBT-acK8R9CpR93qVqFeJGpROElPp1XH-vh3J_a38sZaA10fARGuGLiQxPv7j6gYEFyv37sBRsnHnKehokzpLzgeyi3azf_wf7_-r28FPPm38SfcU-3kfpuRZo46po7-u516vjRyAKwDxAD2po6s</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Lai, Y.-C</creator><creator>Huang, L.-J</creator><creator>Chen, T.-L</creator><creator>Yang, Y.-W</creator><creator>Hsiao, L.-T</creator><creator>Teng, H.-W</creator><creator>Fung, C.-P</creator><creator>Chiou, T.-J</creator><creator>Tzeng, C.-H</creator><creator>Liu, C.-Y</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Impact of Port-A-Cath device management in cancer patients with candidaemia</title><author>Lai, Y.-C ; Huang, L.-J ; Chen, T.-L ; Yang, Y.-W ; Hsiao, L.-T ; Teng, H.-W ; Fung, C.-P ; Chiou, T.-J ; Tzeng, C.-H ; Liu, C.-Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-3bffa4f1e908871685ac8ddb1d6d17b2a0978539e7df401737d0bbdcd1d598633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Candidaemia</topic><topic>Candidemia - therapy</topic><topic>Catheter-Related Infections - epidemiology</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Human mycoses</topic><topic>Humans</topic><topic>Infection Control - methods</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycoses</topic><topic>Mycotic sepsis</topic><topic>Neoplasms - complications</topic><topic>Port-A-Cath</topic><topic>Removal</topic><topic>Retention</topic><topic>Retrospective Studies</topic><topic>Totally implantable central venous access port</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Vascular Access Devices - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lai, Y.-C</creatorcontrib><creatorcontrib>Huang, L.-J</creatorcontrib><creatorcontrib>Chen, T.-L</creatorcontrib><creatorcontrib>Yang, Y.-W</creatorcontrib><creatorcontrib>Hsiao, L.-T</creatorcontrib><creatorcontrib>Teng, H.-W</creatorcontrib><creatorcontrib>Fung, C.-P</creatorcontrib><creatorcontrib>Chiou, T.-J</creatorcontrib><creatorcontrib>Tzeng, C.-H</creatorcontrib><creatorcontrib>Liu, C.-Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lai, Y.-C</au><au>Huang, L.-J</au><au>Chen, T.-L</au><au>Yang, Y.-W</au><au>Hsiao, L.-T</au><au>Teng, H.-W</au><au>Fung, C.-P</au><au>Chiou, T.-J</au><au>Tzeng, C.-H</au><au>Liu, C.-Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Port-A-Cath device management in cancer patients with candidaemia</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>82</volume><issue>4</issue><spage>281</spage><epage>285</epage><pages>281-285</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>Summary This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3–4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>23084483</pmid><doi>10.1016/j.jhin.2012.08.007</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-6701 |
| ispartof | The Journal of hospital infection, 2012-12, Vol.82 (4), p.281-285 |
| issn | 0195-6701 1532-2939 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1178671337 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Cancer Candidaemia Candidemia - therapy Catheter-Related Infections - epidemiology Cohort Studies Female Human mycoses Humans Infection Control - methods Infectious Disease Infectious diseases Male Medical sciences Middle Aged Mycoses Mycotic sepsis Neoplasms - complications Port-A-Cath Removal Retention Retrospective Studies Totally implantable central venous access port Treatment Outcome United States Vascular Access Devices - microbiology |
| title | Impact of Port-A-Cath device management in cancer patients with candidaemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T12%3A56%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Port-A-Cath%20device%20management%20in%20cancer%20patients%20with%20candidaemia&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Lai,%20Y.-C&rft.date=2012-12-01&rft.volume=82&rft.issue=4&rft.spage=281&rft.epage=285&rft.pages=281-285&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2012.08.007&rft_dat=%3Cproquest_cross%3E1178671337%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1178671337&rft_id=info:pmid/23084483&rft_els_id=S0195670112002800&rfr_iscdi=true |